Javascript must be enabled to continue!
A Systematic Review and Meta-analysis of the Prevalence of Schizophrenia in China From 2000 to 2020
View through CrossRef
Abstract
Background
The prevalence of schizophrenia is influenced by many factors.Understanding this change is of academic significance and scientific value.To understand the prevalence of schizophrenia and the trend of nearly twenty years in China, providing scientific basis for early prevention and treatment by meta-analysis.
Methods
A systematic literature retrieval was conducted by using Chinese database for the information about the prevalence of schizophrenia in China published from 2000 to 2020.The quality of literature was evaluated .The prevalence was analyzed by Revman5.2.
Results
Twenty-eight articles were included. The total sample size was 76273830. The prevalence of schizophrenia in China was 3.72 ‰ (95%: 3.30 ‰ - 4.22 ‰). Subgroup analysis showed that there was no significant difference in the prevalence of schizophrenia among cases with different genders(P>0.05) ,among rural and urban(P>0.05),between the years of the survey(P>0.05). The related age range of highest prevalence of schizophrenia was 35-64 years old.
Conclusions
The prevalence of schizophrenia in China is 3.72 ‰. The prevalence rate of Schizophrenia is no difference with genders,urbancity.There was no significant change in prevalence of schizophrenia in the last twenty years.The related age range of highest prevalence of schizophrenia was 35-64 years old.
Title: A Systematic Review and Meta-analysis of the Prevalence of Schizophrenia in China From 2000 to 2020
Description:
Abstract
Background
The prevalence of schizophrenia is influenced by many factors.
Understanding this change is of academic significance and scientific value.
To understand the prevalence of schizophrenia and the trend of nearly twenty years in China, providing scientific basis for early prevention and treatment by meta-analysis.
Methods
A systematic literature retrieval was conducted by using Chinese database for the information about the prevalence of schizophrenia in China published from 2000 to 2020.
The quality of literature was evaluated .
The prevalence was analyzed by Revman5.
2.
Results
Twenty-eight articles were included.
The total sample size was 76273830.
The prevalence of schizophrenia in China was 3.
72 ‰ (95%: 3.
30 ‰ - 4.
22 ‰).
Subgroup analysis showed that there was no significant difference in the prevalence of schizophrenia among cases with different genders(P>0.
05) ,among rural and urban(P>0.
05),between the years of the survey(P>0.
05).
The related age range of highest prevalence of schizophrenia was 35-64 years old.
Conclusions
The prevalence of schizophrenia in China is 3.
72 ‰.
The prevalence rate of Schizophrenia is no difference with genders,urbancity.
There was no significant change in prevalence of schizophrenia in the last twenty years.
The related age range of highest prevalence of schizophrenia was 35-64 years old.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
Abstract
Background
Evidence shows that schizophrenia is associated with increased incidence of cardiovascular diseases (CVD), i...
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
Do evidence summaries increase health policy‐makers' use of evidence from systematic reviews? A systematic review
This review summarizes the evidence from six randomized controlled trials that judged the effectiveness of systematic review summaries on policymakers' decision making, or the most...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Exploring sexual and romantic functioning as early risk factors of schizophrenia: a narrative review
Abstract
Background
Patients with schizophrenia frequently encounter challenges related to sexuality and intimacy; however, the ...
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
Abstract
Background
The role of oral and gut microbiomes in the pathogenesis of schizophrenia has recently come to light with th...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

